Sort
130,381 grants matching “hiv”
CAMPO Clinical Trials Program
$867,605Joel Palefsky · University Of California, San Francisco · U54 · FY2023 · CA
Elite controllers as a model for a cure of HIV-1 infection
$867,590Xu Yu · Massachusetts General Hospital · R37 · FY2021 · AI
Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates
$867,569Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Posttranscriptional control of gene expression
$867,531Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The functional significance of CTL escape
$867,514David I Watkins · George Washington University · R01 · FY2024 · AI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
$867,443John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
$867,443John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
$867,415Mark D Macek · University Of Maryland Baltimore · R01 · FY2022 · DE
Virologic Correlates of Heterosexual Transmission
$867,399Eric Hunter · Emory University · R01 · FY2006 · AI
Multimodal Imaging of NeuroHIV Dynamics (MIND): An Omaha-Pittsburgh Consortium
$867,356Tony W. Wilson · University Of Nebraska Medical Center · R01 · FY2018 · MH
DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet Nam
$867,212Don C Des Jarlais · New York University · R01 · FY2020 · DA
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$867,166Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2025 · AI
Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates
$867,163Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2024 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$867,153Daniel Joseph Daltry · Vermont State Agency Of Human Services · U62 · FY2015 · PS
Natural History of Hepatitis C Infection in HIV Disease
$867,151Deborah Cotton · Boston University Medical Campus · R01 · FY2007 · DA
An Env apex-focused HIV-1 vaccine strategy
$867,099Michael R. Farzan · Boston Children'S Hospital · R01 · FY2025 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$867,084Asim K Debnath · New York Blood Center · R01 · FY2019 · AI
The Functional Significance of CTL Escape
$867,038University Of Wisconsin Madison · R01 · FY2005 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$867,023Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2016 · DE
Optimizing HIV counseling testing and referral through an adaptive drug use intervention
$867,005Rob B Stephenson · University Of Michigan At Ann Arbor · R01 · FY2015 · DA
HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
$866,913Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P01 · FY2013 · MH
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$866,894Tracy M Handel · University Of California, San Diego · U01 · FY2013 · GM
CAMPO Clinical Trials Program
$866,865Joel Palefsky · University Of California, San Francisco · U54 · FY2019 · CA
Role of HIV Env glycosylation in mucosal transmission
$866,864Siddappa N Byrareddy · Emory University · R01 · FY2015 · AI
HIV Reservoir Ecology of Viral Remission
$866,695Jonathan Li · Brigham And Women'S Hospital · R01 · FY2023 · AI